This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Will Expand Drug Arsenal Against Resistant Virus

Joan Stephenson, PhD

JAMA. 2007;297:1535-1536.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Los Angeles—Two investigational drugs that take aim at novel therapeutic targets show promise for treating patients infected with HIV strains that are resistant to existing drugs, according to findings presented here at the 14th Annual Conference on Retroviruses and Opportunistic Infections.

Promising findings are emerging from clinical trials testing 2 new classes of drugs for treating patients infected with drug-resistant HIV. (Photo credit: NIBSC/www.sciencesource.com)

The data, from large efficacy trials, indicate that drug combinations containing the new medications achieved substantial levels of viral suppression in extensively treated patients with drug-resistant HIV. The response of patients was analogous to that seen when highly active antiretroviral therapy first became available, said John Mellors, MD, of the University of Pittsburgh School of Medicine at a press briefing about the new findings. "It's really a remarkable development in the field," added Mellors, who was vice chair of the . . . [Full Text of this Article]

HIV RESISTANCE



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?